AR030620A1 - Compuestos derivados de acido bencenotricarboxilico, un proceso para su preparacion, composicion farmaceutica que los comprenden, metodo para efectuar ensayo y el uso de los mismos para la manufactura de medicamentos como activadores del receptor de insulina y para la preparacion de agentes de diagn - Google Patents
Compuestos derivados de acido bencenotricarboxilico, un proceso para su preparacion, composicion farmaceutica que los comprenden, metodo para efectuar ensayo y el uso de los mismos para la manufactura de medicamentos como activadores del receptor de insulina y para la preparacion de agentes de diagnInfo
- Publication number
- AR030620A1 AR030620A1 ARP010104240A ARP010104240A AR030620A1 AR 030620 A1 AR030620 A1 AR 030620A1 AR P010104240 A ARP010104240 A AR P010104240A AR P010104240 A ARP010104240 A AR P010104240A AR 030620 A1 AR030620 A1 AR 030620A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- compounds
- insulinary
- bencenotricarboxilic
- activators
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 4
- 239000003814 drug Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 239000012190 activator Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 2
- 239000008103 glucose Substances 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 102000003746 Insulin Receptor Human genes 0.000 abstract 1
- 108010001127 Insulin Receptor Proteins 0.000 abstract 1
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 201000001421 hyperglycemia Diseases 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/45—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/51—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Diabetes (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23073800P | 2000-09-07 | 2000-09-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR030620A1 true AR030620A1 (es) | 2003-08-27 |
Family
ID=22866366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010104240A AR030620A1 (es) | 2000-09-07 | 2001-09-06 | Compuestos derivados de acido bencenotricarboxilico, un proceso para su preparacion, composicion farmaceutica que los comprenden, metodo para efectuar ensayo y el uso de los mismos para la manufactura de medicamentos como activadores del receptor de insulina y para la preparacion de agentes de diagn |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6600069B2 (https=) |
| EP (1) | EP1315695B1 (https=) |
| JP (1) | JP2004508348A (https=) |
| AR (1) | AR030620A1 (https=) |
| AT (1) | ATE299491T1 (https=) |
| AU (1) | AU8889101A (https=) |
| CA (1) | CA2421581A1 (https=) |
| DE (1) | DE60111948T2 (https=) |
| DK (1) | DK1315695T3 (https=) |
| ES (1) | ES2241867T3 (https=) |
| TW (1) | TWI283660B (https=) |
| WO (1) | WO2002020464A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1391474B1 (it) * | 2008-10-02 | 2011-12-23 | Università Degli Studi Di Roma La Sapienza | Derivati carbonilici a simmetria c3, loro preparazione e loro uso |
| KR101121954B1 (ko) | 2010-05-13 | 2012-03-09 | 아주대학교산학협력단 | 1,2,3-Ｂｅｎｚｅｎｔｒｉｃａｒｂｏｘｙｌｉｃ ａｃｉｄ를 유효성분으로 포함하는 당뇨병 예방 또는 치료용 조성물 |
| JP6255210B2 (ja) * | 2013-10-24 | 2017-12-27 | アーゼッド・エレクトロニック・マテリアルズ（ルクセンブルグ）ソシエテ・ア・レスポンサビリテ・リミテ | レジスト下層膜形成組成物 |
| US20220288068A1 (en) * | 2019-07-10 | 2022-09-15 | Merck Patent Gmbh | Pharmaceutical preparation |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4051176A (en) | 1976-05-10 | 1977-09-27 | American Cyanamid Company | Ureidophenylenebis(carbonylimino)dinaphthalenetrisulfonic acid compounds |
| US4046805A (en) | 1976-05-10 | 1977-09-06 | American Cyanamid Company | Substituted-hydroxy-naphthalenedisulfonic acid compounds |
| US4129591A (en) | 1976-10-27 | 1978-12-12 | American Cyanamid Company | Ureida-phenylenebis(substituted imino)multianionic substituted dinaphthalene sulfonic acids and salts |
| US4102917A (en) | 1977-06-01 | 1978-07-25 | American Cyanamid Company | Substituted phenyl naphthalenesulfonic acids |
| US4123455A (en) | 1977-06-13 | 1978-10-31 | American Cyanamid Company | Phenenyltris(carbonylimino) multi-anionic substituted triphenyl acids and salts |
| US4089974A (en) | 1977-06-13 | 1978-05-16 | American Cyanamid Company | 5-Carboxy-phenylenebis(carbonylimino)benzene carboxylic and dicarboxylic acids and salts |
| US4120895A (en) | 1977-06-29 | 1978-10-17 | American Cyanamid Company | S-phenenyltris (iminocarbonyl) triisophthalic acid salts |
| US4132730A (en) | 1977-07-29 | 1979-01-02 | American Cyanamid Company | Ureylene naphthalene sulfonic acids |
| US4120891A (en) | 1977-07-01 | 1978-10-17 | American Cyanamid Company | Ureylene naphthalene sulfonic acids |
| US4118585A (en) | 1977-07-01 | 1978-10-03 | American Cyanamid Company | Anionic benzene tetrakis carbonylimino isophthalic acid salts |
| US4229371A (en) * | 1977-07-29 | 1980-10-21 | American Cyanamid Company | Ureylene naphthalene sulfonic acid intermediates |
| CH654853A5 (de) | 1982-08-07 | 1986-03-14 | Sandoz Ag | Verfahren zum verdichten von anodisch oxydierten aluminiumoberflaechen. |
| DE4229182A1 (de) | 1992-09-02 | 1994-03-03 | Basf Ag | Metallchelate |
| US5599984A (en) | 1994-01-21 | 1997-02-04 | The Picower Institute For Medical Research | Guanylhydrazones and their use to treat inflammatory conditions |
| US5973076A (en) | 1995-05-31 | 1999-10-26 | New Japan Chemical Co., Ltd. | Polybutene-1 resin composition and a method of accelerating the crystal transformation thereof |
| US5565432A (en) * | 1994-11-07 | 1996-10-15 | American Home Products Corporation | Smooth muscle cell proliferation inhibitors |
| TR199600329A2 (tr) | 1995-05-05 | 1997-03-21 | Hoffmann La Roche | Seker alkollerin yeni sülfürik asit esterleri. |
| JPH08333324A (ja) * | 1995-06-08 | 1996-12-17 | Terumo Corp | ベンゼン誘導体およびそれを含有する医薬製剤 |
| JP3836910B2 (ja) * | 1996-01-19 | 2006-10-25 | 富士写真フイルム株式会社 | ハロゲン化銀写真感光材料およびその処理方法 |
| EP1277790A3 (en) | 1998-03-04 | 2004-07-28 | Ciba SC Holding AG | Nucleators for crystallizable thermoplastic polymers |
| IL147032A0 (en) | 1999-07-29 | 2002-08-14 | Telik Inc | Novel naphthylsulfonic acids and related compounds as glucose uptake agonists |
-
2001
- 2001-09-06 CA CA002421581A patent/CA2421581A1/en not_active Abandoned
- 2001-09-06 EP EP01968657A patent/EP1315695B1/en not_active Expired - Lifetime
- 2001-09-06 AT AT01968657T patent/ATE299491T1/de not_active IP Right Cessation
- 2001-09-06 AU AU8889101A patent/AU8889101A/xx not_active Withdrawn
- 2001-09-06 DE DE60111948T patent/DE60111948T2/de not_active Expired - Fee Related
- 2001-09-06 DK DK01968657T patent/DK1315695T3/da active
- 2001-09-06 ES ES01968657T patent/ES2241867T3/es not_active Expired - Lifetime
- 2001-09-06 JP JP2002525087A patent/JP2004508348A/ja not_active Withdrawn
- 2001-09-06 TW TW090122095A patent/TWI283660B/zh not_active IP Right Cessation
- 2001-09-06 US US09/949,165 patent/US6600069B2/en not_active Expired - Fee Related
- 2001-09-06 WO PCT/US2001/028084 patent/WO2002020464A2/en not_active Ceased
- 2001-09-06 AR ARP010104240A patent/AR030620A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU8889101A (en) | 2002-03-22 |
| ES2241867T3 (es) | 2005-11-01 |
| TWI283660B (en) | 2007-07-11 |
| US20020103183A1 (en) | 2002-08-01 |
| DK1315695T3 (da) | 2005-08-08 |
| WO2002020464A8 (en) | 2003-07-10 |
| WO2002020464A3 (en) | 2002-06-20 |
| DE60111948D1 (de) | 2005-08-18 |
| EP1315695A2 (en) | 2003-06-04 |
| CA2421581A1 (en) | 2002-03-14 |
| JP2004508348A (ja) | 2004-03-18 |
| DE60111948T2 (de) | 2006-04-20 |
| US6600069B2 (en) | 2003-07-29 |
| ATE299491T1 (de) | 2005-07-15 |
| WO2002020464A2 (en) | 2002-03-14 |
| EP1315695B1 (en) | 2005-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6410287A2 (es) | Composición farmacéutica, forma farmacéutica, procedimiento para su preparación, métodos de tratamiento y usos de la misma | |
| CR9749A (es) | Derivados de xantina como agonistas de hm74a selectivos | |
| AR023401A1 (es) | Derivados de 1,4-benzotiazepina-1,1-dioxido sustituidos con restos de azucar, procedimientos para su preparacion, medicamentos que contienen estoscompuestos, y su empleo para preparar un medicamento | |
| CL2008003153A1 (es) | Compuestos espiro condensados, agonistas de gpr40: composicion farmaceutica que comprende a uno de los compuestos; y el uso de los compuestos en la preparacion de medicamentos para el tratamiento de la diabetes, hiperglicemia, alteracion de tolerancia a la glucosa en ayuna, entre otras. | |
| UY30481A1 (es) | Isoxazolinas sustituidas, composiciones farmaccuticas que contienen a las mismas, metodos de preparacion y usos. | |
| BR0110492A (pt) | Composto, composição farmacêutica que compreende esse composto, processo para a preparação de composição farmacêutica, utilização do composto e processo para a preparação do composto | |
| CL2008002052A1 (es) | Compuestos derivados de pirazol, inhibidores de la 11 beta-hidroxi-esteroide-deshidrogenasa; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y uso para la preparacion de medicamentos para el tratamiento de diabetes, obesidad, trastornos de ingestion de comida o dislipidemia | |
| BRPI0821004A8 (pt) | Composto derivado de aminopirazol, composição farmacêutica que o contem e uso deste | |
| BRPI0609424B8 (pt) | composto inibidor da dipeptidil peptidase-iv e composição farmacêutica compreendendo dito composto como um agente ativo | |
| AR067106A1 (es) | Derivados de imidazo[2,1-b]tiazol moduladores de sirtuina | |
| UY28990A1 (es) | Nuevos derivados de benceno 1, 3-amino carbonilo como inhibidores de b-raf, composiciones farmacéuticas que los contienen, procesos de preparación y uso. | |
| BR0210711A (pt) | Uso de um composto, composição farmacêutica, composto, e, processo para a preparação de um composto | |
| UY30547A1 (es) | Derivados n-sustituidos de la 6-piridin-4-il quinazolin-2-amina, sus estereoisomeros y sales farmacéuticamente aceptables, proceso de preparacion, composiciones y aplicaciones. | |
| BRPI0915592A2 (pt) | composto agonista do receptor de gpr119, processo para a preparação do composto, composição farmacêutica que o compreende, uso do mesmo e método para o tratamento ou profilaxia de diabetes mellitus do tipo ii | |
| BRPI0410760A (pt) | compostos, processo para fabricação dos mesmos, composições farmacêuticas e uso deste compostos | |
| BRPI0612957B8 (pt) | composto, processos de preparação de compostos, composição farmacêutica e uso de um composto | |
| BRPI0517701A (pt) | uso de um composto na preparação de medicamentos para o tratamento de diabetes mellitus | |
| AR047928A1 (es) | Derivados de tetrahidropiridoindol | |
| ECSP088322A (es) | Derivados de fenil-1,2,4-oxadiazolona, procesos para su preparación y su uso como compuestos farmacéuticos | |
| ES2170813T3 (es) | Acidos 2,2-dicloroalcanocarboxilicos, proceso para su preparacion, medicamentos que los contienen y su uso para tratar la resistencia a la insulina. | |
| CL2025000631A1 (es) | Compuestos de insulina acilada de acción temporal prolongada | |
| PE20050923A1 (es) | Composicion solida que comprende un sensibilizador de insulina, un secretagogo de insulina y un ester de acidos grasos | |
| AR056369A1 (es) | Compuestos derivados de quinazolina y composicion farmaceutica | |
| AR030620A1 (es) | Compuestos derivados de acido bencenotricarboxilico, un proceso para su preparacion, composicion farmaceutica que los comprenden, metodo para efectuar ensayo y el uso de los mismos para la manufactura de medicamentos como activadores del receptor de insulina y para la preparacion de agentes de diagn | |
| BRPI0820950A2 (pt) | Composto, formulação farmacêutica, uso de um composto, métodos para o tratamento ou prevenção de condições ou doenças e para inibição da angiogênese, e, processo para a preparação de um composto. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |